08212017Headline:

Denver, Colorado

HomeColoradoDenver

Email Staff Writer Staff Writer on LinkedIn Staff Writer on Twitter Staff Writer on Facebook
Staff Writer
Staff Writer
Contributor •

Depression Device

Comments Off

A Senate Finance Committee found that a top FDA official overruled the unanimous opinion of his scientific staff when he decided last year to approve a pacemaker-like device to treat persistent depression, according to an article in the New York Times. The device has been used since 1997 to treat epilepsy, and when patients began reporting improvements in mood, the manufacturer sought approval for depression.